The journey following a stem cell transplant can be fraught with complications, none more debilitating than chronic graft-versus-host disease, a condition where donor immune cells relentlessly attack the recipient's body. This review assesses Rezurock (belumosudil) as a critical therapeutic option
For individuals grappling with the relentless and often disfiguring effects of cutaneous lupus erythematosus, the path to effective treatment has been long and fraught with limited options, but a significant development from Biogen offers a new beacon of hope. The U.S. Food and Drug Administration
In an era where supply chain resilience and access to life-saving therapies dominate healthcare discussions, AstraZeneca's announcement of a $2 billion investment in Maryland facilities has captured significant attention, raising critical questions about domestic production. This ambitious
In the heart of South Metro Atlanta, a significant shift in healthcare delivery is unfolding with the recent opening of a new medical practice in Newnan, Georgia, promising to redefine how primary care is experienced in the region. This innovative facility, led by a dedicated physician with a
In a startling revelation that underscores the fragility of Malaysia’s public healthcare system, a staggering 293 out of 542 newly posted medical officers failed to report for duty in Sarawak, a state already grappling with severe doctor shortages. This alarming statistic is not just a local
In a landscape where economic volatility often shakes investor confidence, Becton Dickinson (BDX) has emerged as a standout performer, recently revising its full-year earnings outlook upward with an adjusted diluted EPS guidance of $14.30 to $14.45, reflecting a robust 9.4% growth at the midpoint.
